Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

GMP development of CS-TATI-1 begins

Aug. 16, 2012

Treatment begins in phase I trial of SOR-C13

Aug. 16, 2012

Curegenix reports new lysophospholipid LPA1 receptor antagonists

Aug. 16, 2012

Novel B-raf inhibitors divulged by Boehringer Ingelheim

Aug. 16, 2012

Nerviano Medical Sciences discloses new protein kinase inhibitors

Aug. 16, 2012

Novartis patents new CDK9/cyclin-T1 inhibitors

Aug. 16, 2012

Tarceva approved in Canada for specific NSCLC subtype

Aug. 14, 2012

New E.U. approval for Votrient

Aug. 14, 2012

Nagasaki University reports new candidate anticancer products

Aug. 14, 2012

Scientists in China isolate new saponins from bunge fruit

Aug. 14, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...